Aglaia Management B.V.
aglaia-oncology.com Direct investor
Aglaia Management B.V. is a venture capital firm that invests in oncology drug development companies. It manages alternative investment funds and has invested in 12 early stage companies, 6 of which it founded.
Aglaia Management B.V. is a venture capital firm headquartered in Bilthoven, Netherlands. It invests directly in companies, in oncology, drug development and life sciences. 12 portfolio companies, as it reports.
“Aglaia invests in oncology drug development companies.”
— Aglaia Management B.V., own website
- Layer
- Direct investor
- Type
- Venture capital
- Stage
- Not stated
- Headquarters
- Bilthoven, Netherlands
- Sectors
- oncology, drug development, life sciences
- Portfolio
- 12 companies
Team, as Aglaia Management B.V. publishes it
- Karl Rothweiler Partner
- Folkert van Cleef Partner
- Eric van der Putten Partner
- Mark Krul Partner
- Ernst Geutjes Venture Partner
Names and roles exactly as listed on aglaia-oncology.com. Nothing else about these people is recorded.
Where this comes from
Every fact above was read from a page Aglaia Management B.V. publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://aglaia-oncology.com/name, is_investor, layer, type, hq_country, hq_city, sectors, thesis_quote, description, portfolio_count, status, confidence
- https://aglaia-oncology.com/team/people
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 9280 · added 2026-09-29 · link last verified 2026-09-29 · confidence high
Similar investors
- BioGeneration VenturesVenture capital · Seed – Series A · Naarden, Netherlands
- Carduso CapitalVenture capital · Seed – Growth · Groningen, Netherlands
- INKEF CapitalVenture capital · Seed – Series A · Netherlands
- Thuja CapitalVenture capital · Seed – Series A · Leiden, Netherlands
- Value Creation Capital B.V.Venture capital · Seed – Series A · Bilthoven, Netherlands
- 4impact capitalVenture capital · Seed – Series A · The Hague, Netherlands